Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             166 results found
no title author magazine year volume issue page(s) type
1 A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial Skytte, Mads J.

62 Suppl 1 p. 2066-2078
article
2 Adenine nucleotide-mediated regulation of hepatic PTP1B activity in mouse models of type 2 diabetes Yang, Xiao
2019
62 Suppl 1 p. 2106-2117
article
3 Adenine nucleotide-mediated regulation of hepatic PTP1B activity in mouse models of type 2 diabetes Yang, Xiao

62 Suppl 1 p. 2106-2117
article
4 Afternoon exercise is more efficacious than morning exercise at improving blood glucose levels in individuals with type 2 diabetes: a randomised crossover trial Savikj, Mladen
2018
62 Suppl 1 p. 233-237
article
5 A future for CD3 antibodies in immunotherapy of type 1 diabetes Chatenoud, Lucienne

62 Suppl 1 p. 578-581
article
6 Alcohol consumption and incident diabetes: The Atherosclerosis Risk in Communities (ARIC) study He, Xintong
2019
62 Suppl 1 p. 770-778
article
7 Alcohol consumption and incident diabetes: The Atherosclerosis Risk in Communities (ARIC) study He, Xintong

62 Suppl 1 p. 770-778
article
8 Anti-fumarase antibody promotes the dropout of photoreceptor inner and outer segments in diabetic macular oedema Yoshitake, Shin

62 Suppl 1 p. 504-516
article
9 Association between maternal diabetes, being large for gestational age and breast-feeding on being overweight or obese in childhood Kaul, Padma
2018
62 Suppl 1 p. 249-258
article
10 Association of CREBRF variants with obesity and diabetes in Pacific Islanders from Guam and Saipan Hanson, Robert L.

62 Suppl 1 p. 1647-1652
article
11 Basal fatty acid oxidation increases after recurrent low glucose in human primary astrocytes Weightman Potter, Paul G.
2018
62 Suppl 1 p. 187-198
article
12 Beta cell function in type 1 diabetes determined from clinical and fasting biochemical variables Wentworth, John M.
2018
62 Suppl 1 p. 33-40
article
13 Beta cells in type 1 diabetes: mass and function; sleeping or dead? Oram, Richard A.
2019
62 Suppl 1 p. 567-577
article
14 Biomarker panels associated with progression of renal disease in type 1 diabetes Colombo, Marco
2019
62 Suppl 1 p. 1616-1627
article
15 Breastfeeding at night is rarely followed by hypoglycaemia in women with type 1 diabetes using carbohydrate counting and flexible insulin therapy Ringholm, Lene

62 Suppl 1 p. 387-398
article
16 Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program Zhou, Zien
2019
62 Suppl 1 p. 1854-1867
article
17 Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease Heerspink, Hiddo J. L.
2019
62 Suppl 1 p. 1154-1166
article
18 Capturing residual beta cell function in type 1 diabetes Pociot, Flemming
2018
62 Suppl 1 p. 28-32
article
19 Cardiorespiratory fitness, muscular strength and risk of type 2 diabetes: a systematic review and meta-analysis Tarp, Jakob
2019
62 Suppl 1 p. 1129-1142
article
20 Cardiovascular outcome trials of glucose-lowering medications: an update Home, Philip
2019
62 Suppl 1 p. 357-369
article
21 CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor Pagni, Philippe P.
2019
62 Suppl 1 p. 1727-1729
article
22 CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor Pagni, Philippe P.

62 Suppl 1 p. 1727-1729
article
23 CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor. Reply to Pagni PP, Wolf A, Lo Conte M et al [letter] Vaitaitis, Gisela M.
2019
62 Suppl 1 p. 1730-1731
article
24 CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor. Reply to Pagni PP, Wolf A, Lo Conte M et al [letter] Vaitaitis, Gisela M.

62 Suppl 1 p. 1730-1731
article
25 Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance Benhalima, Katrien

62 Suppl 1 p. 2118-2128
article
26 Characteristics of familial type 1 diabetes: effects of the relationship to the affected family member on phenotype and genotype at diagnosis Turtinen, Maaret
2019
62 Suppl 1 p. 2025-2039
article
27 Characteristics of familial type 1 diabetes: effects of the relationship to the affected family member on phenotype and genotype at diagnosis Turtinen, Maaret

62 Suppl 1 p. 2025-2039
article
28 Circulating CXCR5−PD-1hi peripheral T helper cells are associated with progression to type 1 diabetes Ekman, Ilse
2019
62 Suppl 1 p. 1681-1688
article
29 Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts Ahola-Olli, Ari V.

62 Suppl 1 p. 2298-2309
article
30 Circulating metabolites in progression to islet autoimmunity and type 1 diabetes Lamichhane, Santosh

62 Suppl 1 p. 2287-2297
article
31 Comment on ‘Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial’ Amini, Payam
2018
62 Suppl 1 p. 202-203
article
32 Concordance of glycaemic and cardiometabolic traits between Indian women with history of gestational diabetes mellitus and their spouses: an opportunity to target the household Goyal, Alpesh

62 Suppl 1 p. 1357-1365
article
33 Consequences of being overweight or obese during pregnancy on diabetes in the offspring: a record linkage study in Aberdeen, Scotland Lahti-Pulkkinen, Marius
2019
62 Suppl 1 p. 1412-1419
article
34 Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies Kristensen, Karl
2019
62 Suppl 1 p. 1143-1153
article
35 Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters Murphy, Helen R.
2019
62 Suppl 1 p. 1123-1128
article
36 Correction to: In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice Abdulreda, Midhat H.
2019
62 Suppl 1 p. 1517
article
37 Correction to: Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study Abbasi, A.
2019
62 Suppl 1 p. 1518-1519
article
38 Correction to: Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register Steinarsson, Andri O.
2019
62 Suppl 1 p. 2166-2167
article
39 Correction to: Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register Steinarsson, Andri O.

62 Suppl 1 p. 2166-2167
article
40 Cytoplasmic ends of tetraspanin 7 harbour epitopes recognised by autoantibodies in type 1 diabetes Eugster, Anne
2019
62 Suppl 1 p. 805-810
article
41 Cytoplasmic ends of tetraspanin 7 harbour epitopes recognised by autoantibodies in type 1 diabetes Eugster, Anne

62 Suppl 1 p. 805-810
article
42 Deficiency in AIM2 induces inflammation and adipogenesis in white adipose tissue leading to obesity and insulin resistance Gong, Zhenwei

62 Suppl 1 p. 2325-2339
article
43 Deficiency in AIM2 induces inflammation and adipogenesis in white adipose tissue leading to obesity and insulin resistance Gong, Zhenwei

62 Suppl 1 p. 2325-2339
article
44 Developmental overnutrition and obesity and type 2 diabetes in offspring Perng, Wei
2019
62 Suppl 1 p. 1779-1788
article
45 Developmental undernutrition, offspring obesity and type 2 diabetes Stein, Aryeh D.
2019
62 Suppl 1 p. 1773-1778
article
46 DEXI, a candidate gene for type 1 diabetes, modulates rat and human pancreatic beta cell inflammation via regulation of the type I IFN/STAT signalling pathway Dos Santos, Reinaldo S.

62 Suppl 1 p. 459-472
article
47 Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals Ohkuma, Toshiaki
2019
62 Suppl 1 p. 1550-1560
article
48 Digital health technology and mobile devices for the management of diabetes mellitus: state of the art Shan, Rongzi
2019
62 Suppl 1 p. 877-887
article
49 Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium Koivula, Robert W.
2019
62 Suppl 1 p. 1601-1615
article
50 Disruption of beta cell acetyl-CoA carboxylase-1 in mice impairs insulin secretion and beta cell mass Cantley, James
2018
62 Suppl 1 p. 99-111
article
51 DOC2B promotes insulin sensitivity in mice via a novel KLC1-dependent mechanism in skeletal muscle Zhang, Jing
2019
62 Suppl 1 p. 845-859
article
52 DOC2B promotes insulin sensitivity in mice via a novel KLC1-dependent mechanism in skeletal muscle Zhang, Jing

62 Suppl 1 p. 845-859
article
53 Dysregulated expression but redundant function of the long non-coding RNA HOTAIR in diabetic kidney disease Majumder, Syamantak
2019
62 Suppl 1 p. 2129-2142
article
54 Dysregulated expression but redundant function of the long non-coding RNA HOTAIR in diabetic kidney disease Majumder, Syamantak

62 Suppl 1 p. 2129-2142
article
55 Early-life factors contributing to type 1 diabetes Craig, Maria E.
2019
62 Suppl 1 p. 1823-1834
article
56 Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation Azmi, Shazli
2019
62 Suppl 1 p. 1478-1487
article
57 Echocardiography improves prediction of major adverse cardiovascular events in a population with type 1 diabetes and without known heart disease: the Thousand & 1 Study Jensen, Magnus T.

62 Suppl 1 p. 2354-2364
article
58 Echocardiography improves prediction of major adverse cardiovascular events in a population with type 1 diabetes and without known heart disease: the Thousand & 1 Study Jensen, Magnus T.

62 Suppl 1 p. 2354-2364
article
59 Effect of duration and burden of microvascular complications on mortality rate in type 1 diabetes: an observational clinical cohort study Bjerg, Lasse
2019
62 Suppl 1 p. 633-643
article
60 Effect of screening for type 1 diabetes on early metabolic control: the DiPiS study Lundgren, Markus
2018
62 Suppl 1 p. 53-57
article
61 Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study Bergmann, Natasha C.
2019
62 Suppl 1 p. 665-675
article
62 Elevated brain glutamate levels in type 1 diabetes: correlations with glycaemic control and age of disease onset but not with hypoglycaemia awareness status Wiegers, Evita C.
2019
62 Suppl 1 p. 1065-1073
article
63 Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse Jha, Jay C.
2019
62 Suppl 1 p. 1712-1726
article
64 Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse Jha, Jay C.

62 Suppl 1 p. 1712-1726
article
65 Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial Nilsson, Malin

62 Suppl 1 p. 1948-1958
article
66 Expression of GLP-1 receptors in insulin-containing interneurons of rat cerebral cortex Csajbók, Éva A.
2019
62 Suppl 1 p. 717-725
article
67 Factors associated with stillbirth in women with diabetes Mackin, Sharon T.
2019
62 Suppl 1 p. 1938-1947
article
68 Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality Bancks, Michael P.
2019
62 Suppl 1 p. 1366-1374
article
69 Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality Bancks, Michael P.

62 Suppl 1 p. 1366-1374
article
70 Fenofibrate increases very-long-chain sphingolipids and improves blood glucose homeostasis in NOD mice Holm, Laurits J.

62 Suppl 1 p. 2262-2272
article
71 Follow-up at 1 year and beyond of women with gestational diabetes treated with insulin and/or oral glucose-lowering agents: a core outcome set using a Delphi survey Bogdanet, Delia
2019
62 Suppl 1 p. 2007-2016
article
72 Follow-up at 1 year and beyond of women with gestational diabetes treated with insulin and/or oral glucose-lowering agents: a core outcome set using a Delphi survey Bogdanet, Delia

62 Suppl 1 p. 2007-2016
article
73 Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis Herrero-Cervera, Andrea
2019
62 Suppl 1 p. 2143-2157
article
74 Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis Herrero-Cervera, Andrea

62 Suppl 1 p. 2143-2157
article
75 Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis Kramer, Caroline K.
2019
62 Suppl 1 p. 905-914
article
76 Global trends in diabetes complications: a review of current evidence Harding, Jessica L.
2018
62 Suppl 1 p. 3-16
article
77 Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016 Mair, Colette
2019
62 Suppl 1 p. 1375-1384
article
78 Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmö Diet and Cancer–Cardiovascular Cohort Bao, Xue
2018
62 Suppl 1 p. 78-86
article
79 Human gut microbiota transferred to germ-free NOD mice modulate the progression towards type 1 diabetes regardless of the pace of beta cell function loss in the donor Neuman, Vit
2019
62 Suppl 1 p. 1291-1296
article
80 Human gut microbiota transferred to germ-free NOD mice modulate the progression towards type 1 diabetes regardless of the pace of beta cell function loss in the donor Neuman, Vit

62 Suppl 1 p. 1291-1296
article
81 Ideal cardiovascular health, glycaemic status and incident type 2 diabetes mellitus: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study Joseph, Joshua J.
2019
62 Suppl 1 p. 426-437
article
82 Impaired whole-body heat loss in type 1 diabetes during exercise in the heat: a cause for concern? Notley, Sean R.
2019
62 Suppl 1 p. 1087-1089
article
83 Impaired whole-body heat loss in type 1 diabetes during exercise in the heat: a cause for concern? Notley, Sean R.

62 Suppl 1 p. 1087-1089
article
84 Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide Thivolet, Charles

62 Suppl 1 p. 593-597
article
85 Induced pluripotent stem cell macrophages present antigen to proinsulin-specific T cell receptors from donor-matched islet-infiltrating T cells in type 1 diabetes Joshi, Kriti

62 Suppl 1 p. 2245-2251
article
86 In search of causal pathways in diabetes: a study using proteomics and genotyping data from a cross-sectional study Beijer, Kristina
2019
62 Suppl 1 p. 1998-2006
article
87 In search of causal pathways in diabetes: a study using proteomics and genotyping data from a cross-sectional study Beijer, Kristina

62 Suppl 1 p. 1998-2006
article
88 In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice Abdulreda, Midhat H.
2019
62 Suppl 1 p. 1237-1250
article
89 In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice Abdulreda, Midhat H.

62 Suppl 1 p. 1237-1250
article
90 Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence Skog, Oskar
2019
62 Suppl 1 p. 1097-1099
article
91 Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence Skog, Oskar

62 Suppl 1 p. 1097-1099
article
92 Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence. Reply to Skog O, Klingel K, Roivainen M et al [letter] Dunne, Jessica L.
2019
62 Suppl 1 p. 1100-1103
article
93 Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence. Reply to Skog O, Klingel K, Roivainen M et al [letter] Dunne, Jessica L.

62 Suppl 1 p. 1100-1103
article
94 Locally delivered GLP-1 analogues liraglutide and exenatide enhance microvascular perfusion in individuals with and without type 2 diabetes Aung, Myo Myo
2019
62 Suppl 1 p. 1701-1711
article
95 Long-term c-Kit overexpression in beta cells compromises their function in ageing mice Oakie, Amanda
2019
62 Suppl 1 p. 1430-1444
article
96 Long-term c-Kit overexpression in beta cells compromises their function in ageing mice Oakie, Amanda

62 Suppl 1 p. 1430-1444
article
97 Long-term exposure to ambient fine particulate matter (PM2.5) and incident type 2 diabetes: a longitudinal cohort study Lao, Xiang Qian
2019
62 Suppl 1 p. 759-769
article
98 Loss of arginine vasopressin- and vasoactive intestinal polypeptide-containing neurons and glial cells in the suprachiasmatic nucleus of individuals with type 2 diabetes Hogenboom, Rick
2019
62 Suppl 1 p. 2088-2093
article
99 Loss of arginine vasopressin- and vasoactive intestinal polypeptide-containing neurons and glial cells in the suprachiasmatic nucleus of individuals with type 2 diabetes Hogenboom, Rick

62 Suppl 1 p. 2088-2093
article
100 Loss of X-box binding protein 1 in Müller cells augments retinal inflammation in a mouse model of diabetes Yang, Jing

62 Suppl 1 p. 531-543
article
101 Macrophage alterations in islets of obese mice linked to beta cell disruption in diabetes Chan, Jeng Yie
2019
62 Suppl 1 p. 993-999
article
102 Macrophage alterations in islets of obese mice linked to beta cell disruption in diabetes Chan, Jeng Yie

62 Suppl 1 p. 993-999
article
103 Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes Tyndall, Victoria
2019
62 Suppl 1 p. 1349-1356
article
104 Maternal glucose levels during pregnancy and childhood adiposity in the Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study Lowe, William L.
2019
62 Suppl 1 p. 598-610
article
105 Maternal metabolites during pregnancy are associated with newborn outcomes and hyperinsulinaemia across ancestries Kadakia, Rachel

62 Suppl 1 p. 473-484
article
106 Mechanisms of hyperinsulinaemia in apparently healthy non-obese young adults: role of insulin secretion, clearance and action and associations with plasma amino acids Hamley, Steven

62 Suppl 1 p. 2310-2324
article
107 Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans Bensellam, Mohammed

62 Suppl 1 p. 2273-2286
article
108 Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study Bryrup, Thomas
2019
62 Suppl 1 p. 1024-1035
article
109 Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality Strelitz, Jean
2019
62 Suppl 1 p. 1391-1402
article
110 Modulation of the p75 neurotrophin receptor using LM11A-31 prevents diabetes-induced retinal vascular permeability in mice via inhibition of inflammation and the RhoA kinase pathway Elshaer, Sally L.
2019
62 Suppl 1 p. 1488-1500
article
111 Molecular regulation of the renin–angiotensin system by sodium–glucose cotransporter 2 inhibition in type 1 diabetes mellitus Kopecky, Chantal
2019
62 Suppl 1 p. 1090-1093
article
112 Molecular regulation of the renin–angiotensin system by sodium–glucose cotransporter 2 inhibition in type 1 diabetes mellitus Kopecky, Chantal

62 Suppl 1 p. 1090-1093
article
113 Neoepitopes: a new take on beta cell autoimmunity in type 1 diabetes Mannering, Stuart I.
2018
62 Suppl 1 p. 351-356
article
114 Neprilysin inhibition: a new therapeutic option for type 2 diabetes? Esser, Nathalie
2019
62 Suppl 1 p. 1113-1122
article
115 Nerve growth factor gene therapy improves bone marrow sensory innervation and nociceptor-mediated stem cell release in a mouse model of type 1 diabetes with limb ischaemia Dang, Zexu
2019
62 Suppl 1 p. 1297-1311
article
116 Neurocognitive and behavioural outcomes in offspring exposed to maternal pre-existing diabetes: a systematic review and meta-analysis Yamamoto, Jennifer M.

62 Suppl 1 p. 1561-1574
article
117 New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism Eid, Stephanie
2019
62 Suppl 1 p. 1539-1549
article
118 No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation Harati, Hadi
2019
62 Suppl 1 p. 800-804
article
119 Non-traditional biomarkers and incident diabetes in the Diabetes Prevention Program: comparative effects of lifestyle and metformin interventions Goldberg, Ronald B.
2018
62 Suppl 1 p. 58-69
article
120 Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study Brahimaj, Adela
2019
62 Suppl 1 p. 1581-1590
article
121 Novel therapeutic potential of angiotensin receptor 1 blockade in a rat model of diabetes-associated depression parallels altered BDNF signalling Lenart, Lilla
2019
62 Suppl 1 p. 1501-1513
article
122 Operational immune tolerance towards transplanted allogeneic pancreatic islets in mice and a non-human primate Abdulreda, Midhat H.
2019
62 Suppl 1 p. 811-821
article
123 Operational immune tolerance towards transplanted allogeneic pancreatic islets in mice and a non-human primate Abdulreda, Midhat H.

62 Suppl 1 p. 811-821
article
124 Outcomes of people with severe hypoglycaemia requiring prehospital emergency medical services management: a prospective study Villani, Melanie
2019
62 Suppl 1 p. 1868-1879
article
125 Outcomes of people with severe hypoglycaemia requiring prehospital emergency medical services management: a prospective study Villani, Melanie

62 Suppl 1 p. 1868-1879
article
126 Perinatal risk factors for type 1 diabetes revisited: a population-based register study Waernbaum, Ingeborg
2019
62 Suppl 1 p. 1173-1184
article
127 Persistent effects of in utero overnutrition on offspring adiposity: the Exploring Perinatal Outcomes among Children (EPOCH) study Hockett, Christine W.

62 Suppl 1 p. 2017-2024
article
128 Phenotypically distinct anti-insulin B cells repopulate pancreatic islets after anti-CD20 treatment in NOD mice Boldison, Joanne
2019
62 Suppl 1 p. 2052-2065
article
129 Phenotypically distinct anti-insulin B cells repopulate pancreatic islets after anti-CD20 treatment in NOD mice Boldison, Joanne

62 Suppl 1 p. 2052-2065
article
130 Phenotypic alterations in pancreatic lymph node stromal cells from human donors with type 1 diabetes and NOD mice Postigo-Fernandez, Jorge
2019
62 Suppl 1 p. 2040-2051
article
131 Phenotypic alterations in pancreatic lymph node stromal cells from human donors with type 1 diabetes and NOD mice Postigo-Fernandez, Jorge

62 Suppl 1 p. 2040-2051
article
132 Pleiotrophin deletion alters glucose homeostasis, energy metabolism and brown fat thermogenic function in mice Sevillano, Julio
2018
62 Suppl 1 p. 123-135
article
133 Postprandial hypoglycaemia after Roux-en-Y gastric bypass in individuals with type 2 diabetes Guarino, Daniela
2018
62 Suppl 1 p. 178-186
article
134 Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study Steineck, Isabelle I. K.
2019
62 Suppl 1 p. 582-592
article
135 Proinsulin peptide promotes autoimmune diabetes in a novel HLA-DR3-DQ2-transgenic murine model of spontaneous disease Verhagen, Johan

62 Suppl 1 p. 2252-2261
article
136 Prostaglandin E2/EP2 receptor signalling pathway promotes diabetic retinopathy in a rat model of diabetes Wang, Man
2018
62 Suppl 1 p. 335-348
article
137 Randomised, phase 1, dose-finding study of MEDI4166, a PCSK9 antibody and GLP-1 analogue fusion molecule, in overweight or obese patients with type 2 diabetes mellitus Jain, Meena
2018
62 Suppl 1 p. 373-386
article
138 Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes Dunne, Jessica L.
2019
62 Suppl 1 p. 744-753
article
139 Screening for type 1 diabetes: are we nearly there yet? Narendran, Parth
2018
62 Suppl 1 p. 24-27
article
140 Selective deletion of endothelial cell calpain in mice reduces diabetic cardiomyopathy by improving angiogenesis Teng, Xiaomei
2019
62 Suppl 1 p. 860-872
article
141 Serum kidney injury molecule 1 and β2-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetes Colombo, Marco
2018
62 Suppl 1 p. 156-168
article
142 Soluble receptor for AGE in diabetic nephropathy and its progression in Finnish individuals with type 1 diabetes Wadén, Jenny M.
2019
62 Suppl 1 p. 1268-1274
article
143 Substrate metabolism, hormone and cytokine levels and adipose tissue signalling in individuals with type 1 diabetes after insulin withdrawal and subsequent insulin therapy to model the initiating steps of ketoacidosis Voss, Thomas S.

62 Suppl 1 p. 494-503
article
144 Synergistic activation of thermogenic adipocytes by a combination of PPARγ activation, SMAD3 inhibition and adrenergic receptor activation ameliorates metabolic abnormalities in rodents Matsumoto, Tomohiro
2019
62 Suppl 1 p. 1915-1927
article
145 Synergistic activation of thermogenic adipocytes by a combination of PPARγ activation, SMAD3 inhibition and adrenergic receptor activation ameliorates metabolic abnormalities in rodents Matsumoto, Tomohiro

62 Suppl 1 p. 1915-1927
article
146 Targeting gut microbiota and barrier function with prebiotics to alleviate autoimmune manifestations in NOD mice Hansen, Camilla H. F.
2019
62 Suppl 1 p. 1689-1700
article
147 Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in individuals with LADA Shi, Xiajie
2018
62 Suppl 1 p. 399-407
article
148 The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study Au Yeung, Shiu Lun

62 Suppl 1 p. 1638-1646
article
149 The role of coronary artery calcification testing in incident coronary artery disease risk prediction in type 1 diabetes Guo, Jingchuan
2018
62 Suppl 1 p. 259-268
article
150 The role of GIP and pancreatic GLP-1 in the glucoregulatory effect of DPP-4 inhibition in mice Hutch, Chelsea R.
2019
62 Suppl 1 p. 1928-1937
article
151 The transcription factor STAT6 plays a critical role in promoting beta cell viability and is depleted in islets of individuals with type 1 diabetes Leslie, Kaiyven A.
2018
62 Suppl 1 p. 87-98
article
152 Trajectories of childhood BMI and adult diabetes: the Bogalusa Heart Study Zhang, Tao
2018
62 Suppl 1 p. 70-77
article
153 Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis Perdigoto, Ana Luisa

62 Suppl 1 p. 655-664
article
154 Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989–2013: a multicentre prospective registration study Patterson, Christopher C.
2018
62 Suppl 1 p. 408-417
article
155 Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes Thomas, Nicholas J.
2019
62 Suppl 1 p. 1167-1172
article
156 Up front 2019
62 Suppl 1 p. 349-350
article
157 Urinary bisphenol A concentration and glucose homeostasis in non-diabetic adults: a repeated-measures, longitudinal study Wang, Bin

62 Suppl 1 p. 1591-1600
article
158 Vascular endothelial PDPK1 plays a pivotal role in the maintenance of pancreatic beta cell mass and function in adult male mice Obata, Atsushi

62 Suppl 1 p. 1225-1236
article
159 VEGF-A and blood vessels: a beta cell perspective Staels, Willem
2019
62 Suppl 1 p. 1961-1968
article
160 VEGF-A and blood vessels: a beta cell perspective Staels, Willem

62 Suppl 1 p. 1961-1968
article
161 What do we know about the trends in incidence of childhood-onset type 1 diabetes? Lawrence, Jean M.

62 Suppl 1 p. 370-372
article
162 What has zinc transporter 8 autoimmunity taught us about type 1 diabetes? Williams, Claire L.
2019
62 Suppl 1 p. 1969-1976
article
163 What has zinc transporter 8 autoimmunity taught us about type 1 diabetes? Williams, Claire L.

62 Suppl 1 p. 1969-1976
article
164 What should governments be doing to prevent diabetes throughout the life course? Timpel, Patrick
2019
62 Suppl 1 p. 1842-1853
article
165 White coat hypertension in early pregnancy in women with pre-existing diabetes: prevalence and pregnancy outcomes Vestgaard, Marianne

62 Suppl 1 p. 2188-2199
article
166 White coat hypertension in early pregnancy in women with pre-existing diabetes: prevalence and pregnancy outcomes Vestgaard, Marianne

62 Suppl 1 p. 2188-2199
article
                             166 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands
Toegankelijkheidsverklaring